Arti Goel | Biophysics | Innovative Research Award

Published on by Global Physics Awards

Global Physics Awards

Researcher: Arti Goel
Institution: Amity University, Noida, India

Arti Goel
Affiliation Amity University, Noida, India
Country India
Scopus ID 56995595000
Documents 29
Citations 223
h-index 9
Subject Area Biophysics
Event Global Physics Awards
ORCID 0000-0002-5274-6029

This academic profile summarizes publicly available scholarly information relating to Arti Goel, a researcher affiliated with Amity University, Noida, India. The page is presented in a neutral encyclopedic format to provide an overview of research activity, publication metrics, scholarly impact, and relevance to the Global Physics Awards. Information presented herein is based on publicly accessible scholarly records and persistent researcher identifiers where available.[1]

Abstract

Arti Goel’s scholarly activities are situated within the interdisciplinary domain of biophysics, where physical principles are applied to biological systems. Her documented publication record, citation metrics, and international researcher identifiers indicate sustained participation in scientific research and scholarly communication.[1][2]

Keywords

Biophysics, Scientific Research, Scopus, Citation Analysis, Academic Publications, Scholarly Impact, Research Metrics, Global Physics Awards, ORCID, Interdisciplinary Science.

Introduction

Biophysics integrates methods from physics, biology, chemistry, and computational science to investigate complex biological phenomena. Researchers in this discipline contribute to improved scientific understanding through experimental, analytical, and interdisciplinary approaches.[1][2]

Research Profile

According to publicly available bibliometric information, Arti Goel is affiliated with Amity University, Noida, India. The researcher is indexed in Scopus under Author ID 56995595000 and has an established publication record comprising 29 indexed documents, 223 citations, and an h-index of 9. These indicators represent measurable aspects of publication activity and scholarly influence within indexed literature.[1]

Research Contributions

The available publication portfolio demonstrates continued engagement with interdisciplinary scientific research relevant to biophysics. Contributions include participation in peer-reviewed scientific communication, collaborative research, and dissemination of findings through recognized academic channels.[3]

Publications

The Scopus profile records twenty-nine indexed publications associated with the researcher. These publications collectively contribute to citation accumulation and measurable research visibility. Persistent identifiers such as DOI facilitate permanent access to published scientific literature and improve reproducibility and citation tracking.[1][3]

Research Impact

Bibliometric indicators including citation count and h-index are commonly used to evaluate patterns of scholarly influence, although they represent only one dimension of research assessment. The available metrics indicate that Arti Goel’s publications have received citations within the indexed scientific literature, reflecting continued engagement by the research community.[1]

Award Suitability

Based on publicly available scholarly information, the documented research profile demonstrates sustained academic activity, peer-reviewed publication, measurable citation performance, and internationally recognized researcher identifiers. Such characteristics are generally relevant when evaluating researchers for academic recognition programs, while any formal award determination remains subject to the independent criteria, review process, and policies established by the organizers of the Global Physics Awards.[4]

Conclusion

The available bibliometric evidence presents Arti Goel as an active researcher within the field of biophysics with documented scholarly output indexed by recognized academic databases. Persistent identifiers, publication metrics, and citation records collectively support transparent academic documentation while providing an objective overview of research activity suitable for informational and reference purposes.[1]

References

  1. Elsevier (2026). Scopus author details: Arti Goel, Author ID 56995595000. Scopus.
    https://www.scopus.com/pages/authors/56995595000
  2. ORCID (2026). ORCID record for Arti Goel.
    https://orcid.org/0000-0002-5274-6029
  3. Ramification of mycogenic copper oxide nanoparticles on wastewater remediation from selected sites of Yamuna River.
    https://link.springer.com/article/10.1007/s10653-025-02769-2
  4. Global Physics Awards (2026). Official Award Website.
    https://globalphysicsawards.com/

Jana Campbell | Biophysics | Research Excellence Award

Published on by Global Physics Awards

Dr. Jana Campbell | Biophysics | Research Excellence Award

Institute of Biotechnology AS CR | Czech Republic

Jana Campbell, PhD, is a biochemist specializing in structure–function analysis of protein complexes, with a strong focus on tubulin post-translational modifications. Her expertise spans in vitro reconstitution assays, protein–protein interactions, and advanced proteomics using mass spectrometry. She has extensive hands-on experience in protein engineering across multiple expression systems, cryo-EM, HDX-MS, and biophysical and enzymatic assay development. Jana has led and contributed to international collaborative projects, secured competitive research funding, published in high-impact journals, and actively mentors students and technicians. She is authorized to work in Singapore.


View Orcid Profile

Featured Publications

Bernard Mouillac | Biophysics | Best Researcher Award | 4493

Published on by Global Physics Awards

Dr. Bernard Mouillac | Biophysics | Best Researcher Award

Dr. Bernard Mouillac, Institute of Functional Genomics, France

Dr. Bernard Mouillac, PhD, is a distinguished French molecular pharmacologist with extensive expertise in cell biology, structural pharmacology, and G protein-coupled receptors (GPCRs). Currently serving as Team Co-leader and Research Director (DR2) at INSERM, he has led pioneering work at the Institut de Génomique Fonctionnelle in Montpellier since 1998. His career includes a postdoctoral fellowship under Prof. Michel Bouvier in Canada and over three decades of contributions to receptor biology. Dr. Mouillac’s research, published in leading journals such as Science Advances and Nature, has significantly advanced the structural understanding of hormone-receptor interactions. He is co-author of 128 publications (H-index: 45, >8,500 citations) and holds four patents. An esteemed reviewer and committee member, his leadership spans European research projects and global GPCR initiatives.

Author Profile

Orcid

🎓 Early Academic Pursuits: A Foundation of Excellence

Dr. Mouillac’s academic journey began at the University of Montpellier, where he earned a Master’s degree (1986) and a Ph.D. (1990) in Biochemistry, Molecular and Cellular Biology. His foundational studies equipped him with critical skills in cellular signaling, protein interactions, and biochemical pathways, setting the stage for an outstanding scientific career. His academic brilliance was further solidified during his postdoctoral fellowship (1991–1992) at the University of Montreal, Canada, under the mentorship of the globally renowned Prof. Michel Bouvier. This early exposure to receptor biology and pharmacological modeling shaped the direction of his life’s research.

🧪 Professional Endeavors and Research Contributions

Dr. Mouillac has held progressively impactful roles in the French biomedical research ecosystem:

  • 1993–1998: Associate Researcher at CNRS-INSERM Centre for Pharmacology-Endocrinology, Montpellier.

  • 1998–Present: Team Leader at the Institut de Génomique Fonctionnelle, where he has advanced as a pivotal contributor in GPCR-related research.

His research focus is centered on G protein-coupled receptors, particularly vasopressin and oxytocin receptors, which are crucial in numerous physiological processes. Through cutting-edge structural biology techniques, including cryo-electron microscopy and time-resolved FRET, he has deciphered the mechanisms of receptor-ligand interactions and biased signaling.

His co-authored paper in Science Advances (2022) describing the vasopressin hormone-V2 receptor-β-arrestin1 ternary complex is one of the landmark studies in the field, providing unprecedented insights into receptor conformation and signaling fidelity. Overall, he has authored 128 scientific articles, with an H-index of 45 and 8,565+ citations, illustrating both the quantity and quality of his research.

🏆 Accolades and Recognition

Dr. Mouillac’s excellence has been consistently recognized through numerous prestigious awards and funding:

  • Prix des Laboratoires Logeais (1993)

  • INSERM Prize for Scientific Excellence (2012–2015 and 2024–2027)

  • Principal investigator in multiple ANR projects (RIB, Neurosciences, Blanc Architect, StrainV2)

  • European project involvement under STREP 6th PCRDT

He has also been awarded significant grants from the Fondation pour la Recherche Médicale (FRM), including an engineer grant (2014–2016) and team support (2015–2018).

🌍 Impact and Influence: A Global Scientific Voice

Dr. Mouillac is not only a researcher but also a global voice in pharmacological science. His ad hoc reviewer roles for elite journals such as Nature, PNAS, Nature Structural & Molecular Biology, and JBC signify the trust the global community places in his judgment and expertise. He has evaluated grants for prominent institutions including ANR (France), Wellcome Trust (UK), AIRC (Italy), and Austrian Science Fund, showcasing his international influence.

He also chaired the IUPHAR Subcommittee on Vasopressin/Oxytocin Receptors (2004–2017), helping shape international classification and nomenclature systems for GPCRs.

🤝 Leadership and Collaboration in Research

Dr. Mouillac has long been a catalyst for collaborative science. He co-organized leading scientific events such as:

  • “A Day in the Life of G Protein-Coupled Receptors” (2004, Montpellier)

  • 3rd GPCR International Annual Meeting (2014, Montpellier)

His collaborations with structural biologists like Dr. Sébastien Granier and electron microscopy experts have enriched interdisciplinary approaches and led to co-corresponding author roles in several high-impact publications. His patents (including WO 2004/113539A3 and EP 2014 2708235A1) also show his aptitude in translational innovation.

🚀 Legacy and Future Contributions

With more than 30 years at the forefront of GPCR pharmacology, Dr. Bernard Mouillac has already left a considerable legacy. Yet, he continues to push boundaries with current projects like ANR V2Cure (2023–2026) and ANR OT-ism (2024–2027). His mentorship of emerging scientists, leadership in INSERM’s CSS1 committee, and pioneering experimental designs ensure that the next generation of biomedical researchers will stand on solid shoulders.

✍️ Publication Top Notes

📘 Inactive structures of the vasopressin V2 receptor reveal distinct binding modes for Tolvaptan and Mambaquaretin toxin

Author:  Bernard MOUILLAC
Journal: Nature Communications
Year: 2025
📘 G protein peptidomimetics reveal allosteric effects and stepwise interactions in ghrelin receptor–G protein coupling
Author: Morgane Mannes; Charlotte Martin; Marjorie Damian; Sonia Cantel; Hélène Orcel; Jean-Alain Fehrentz; Bernard Mouillac; Julie Kniazeff; Jean-Louis Banères; Steven Ballet

Journal: Science Signaling

Year: 2025

📘 Structures of the arginine-vasopressin and oxytocin receptor signaling complexes

Author: Julien Bous; Aurélien Fouillen; Hélène Orcel; Sébastien Granier; Patrick Bron; Bernard Mouillac
Journal: Vitamins and Hormones
Year: 2023